Alternatives to Create Medicines

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Accelerating patient access to evidence-based innovation in mental health.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

Developing highly targeted, small molecule medicines.

A pharmaceutical company focused on developing long-acting injectable medicines.

AI-powered antibody discovery platform.

Advancing next-generation mRNA medicines.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Clinical-stage biotech company targeting RNA modifications for novel cancer therapies.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

AI platform for engineering molecular glues to create a new class of medicines.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing first-in-class oral therapy for BK polyomavirus infections.

A biotechnology company focused on oncology drug discovery.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.

Developing small-molecule modulators of lysosomal ion channels for neurodegenerative diseases.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Developing novel male contraceptives.

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Scalable, one-time curative in-vivo gene editing therapies.

A biopharmaceutical company focused on drug discovery and development.

Advancing targeted alpha therapies.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Biotechnology company developing novel therapeutics by harnessing the autophagy pathway to treat serious diseases.